Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 501,959 |
|
|||||
| News | (1) | ||||||
| Day High | 1.02 | Low High |
|||||
| Day Low | 0.902 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| ABVC BioPharma Inc | ABVC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0928 | -9.02% | 0.9357 | 14:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.00 | 0.902 | 1.02 | 0.935 | 1.0285 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,762 | 501,959 | US$ 0.9522105 | US$ 477,971 | - | 0.6739 - 7.036 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 08:56:24 | 40 | US$ 0.9399 | USD |
ABVC BioPharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9.82M | 10.56M | - | 152k | -10.52M | -1.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ABVC BioPharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 24/5/2024 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 24/5/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 24/5/2024 | 06:30 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 23/5/2024 | 07:00 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 23/5/2024 | 04:31 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 18/5/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 18/5/2024 | 06:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 16/5/2024 | 07:00 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 15/5/2024 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09/5/2024 | 23:27 | Edgar (US Regulatory) | Form 8-K - Current report |
| 18/4/2024 | 23:25 | GlobeNewswire Inc. | AiBtl BioPharma Inc. Acquired TT Life Company, Valued at.. |
| 17/4/2024 | 23:00 | GlobeNewswire Inc. | ABVC BioPharma Executes a Global Licensing Definitive.. |
Historical ABVC Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.07 | 1.10 | 0.902 | 1.06 | 155,074 | -0.1343 | -12.55% |
| 1 Month | 1.4901 | 1.57 | 0.902 | 1.21 | 552,556 | -0.5544 | -37.21% |
| 3 Months | 1.22 | 1.73 | 0.902 | 1.30 | 1,208,147 | -0.2843 | -23.30% |
| 6 Months | 1.89 | 2.45 | 0.902 | 1.61 | 1,502,725 | -0.9543 | -50.49% |
| 1 Year | 6.70 | 7.036 | 0.6739 | 1.93 | 1,575,001 | -5.76 | -86.03% |
| 3 Years | 33.20 | 116.883 | 0.6739 | 17.59 | 1,008,314 | -32.26 | -97.18% |
| 5 Years | 33.20 | 116.883 | 0.6739 | 17.59 | 1,008,314 | -32.26 | -97.18% |
